Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 16, 2023 - Issue
Submit an article Journal homepage
150
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Generalized Vitiligo After Stem Cell Transplantation: A Case Report

Yunxia Wang1 Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People’s Republic of China;2 Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou, Zhejiang Province, People’s Republic of China;3 Department of Dermatology, Hangzhou Clinical College of Anhui Medical University, Hangzhou, Zhejiang Province, People’s Republic of China
,
Wenting Hu2 Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou, Zhejiang Province, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4639-9056
ORCID Icon,
Fuquan Lin2 Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou, Zhejiang Province, People’s Republic of China;3 Department of Dermatology, Hangzhou Clinical College of Anhui Medical University, Hangzhou, Zhejiang Province, People’s Republic of China
&
Ai′e Xu2 Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou, Zhejiang Province, People’s Republic of ChinaCorrespondence[email protected]
Pages 1945-1948 | Received 26 May 2023, Accepted 18 Jul 2023, Published online: 25 Jul 2023

References

  • Kröger N. Preventing graft-versus-host disease without losing graft-versus-leukemia effect after allogeneic stem-cell transplantation. J Clin Oncol. 2020;38(29):3357–3360. doi:10.1200/JCO.20.01756
  • Socié G, Kean LS, Zeiser R, Blazar BR. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease. J Clin Invest. 2021;131(12). doi:10.1172/JCI149296
  • Dai J, Hight RS, Grullon K, Xiao TL, Stein SL. Vitiligo-like manifestations of graft-versus-host disease in a pediatric population. Pediatr Dermatol. 2023;40(1):157–161. doi:10.1111/pde.15121
  • Sanli H, Akay BN, Arat M, et al. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology. 2008;216(4):349–354. doi:10.1159/000117705
  • Koyama M, Mukhopadhyay P, Schuster IS, et al. MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity. 2019;51(5):885–898. doi:10.1016/j.immuni.2019.08.011
  • Richmond JM, Bangari DS, Essien KI, et al. Keratinocyte-derived chemokines orchestrate T-Cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. J Invest Dermatol. 2017;137(2):350. doi:10.1016/j.jid.2016.09.016
  • Rashighi M, Agarwal P, Richmond JM, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 2014;6(223):223ra23–ra23. doi:10.1126/scitranslmed.3007811
  • Sabat R, Wolk K, Loyal L, Döcke W-D, Ghoreschi K. T cell pathology in skin inflammation. Semin Immunopathol. 2019;41(3):359–377. doi:10.1007/s00281-019-00742-7
  • Yardman-Frank JM, Fisher DE. Skin pigmentation and its control: from ultraviolet radiation to stem cells. Exp Dermatol. 2021;30(4):560–571. doi:10.1111/exd.14260
  • Zeiser R, Blazar BR, Longo DL. Pathophysiology of chronic Graft-versus-host disease and therapeutic Targets. N Engl J Med. 2017;377(26):2565–2579. doi:10.1056/NEJMra1703472

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.